Second round of COVID booster sought as concerns of efficacy after six months for immune-compromise

As new-case COVID numbers maintain a downward trend, both drug manufacturers Pfizer and Moderna are asking the Federal Drug Administration and Centers for Disease Control for a recommendation for yet another booster in the vaccination protocol.

Want to read more?

Subscribe to tricityrecord.com to keep reading this exclusive post.

Subscribe Now